title: Cetuximab in refractory squamous cell carcinoma of the anal canal.
authors.affiliation: Pharmacy Clinical Programs, U.T.M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA, jerogers@mdanderson.org.
authors.forename: Jane E
authors.initials: JE
authors.lastname: Rogers
authors.forename: Cathy
authors.initials: C
authors.lastname: Eng
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001005:Anus Neoplasms / Q000188:drug therapy* / Q000473:pathology; D002294:Carcinoma, Squamous Cell / Q000188:drug therapy* / Q000473:pathology; D000068818:Cetuximab; D002945:Cisplatin / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008875:Middle Aged; D014747:Vinblastine / Q000008:administration & dosage / Q000031:analogs & derivatives; D000077235:Vinorelbine
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D014747:Vinblastine; D000068818:Cetuximab; D002945:Cisplatin; D000077235:Vinorelbine